CU20110071A7 - COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS - Google Patents

COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS

Info

Publication number
CU20110071A7
CU20110071A7 CU20110071A CU20110071A CU20110071A7 CU 20110071 A7 CU20110071 A7 CU 20110071A7 CU 20110071 A CU20110071 A CU 20110071A CU 20110071 A CU20110071 A CU 20110071A CU 20110071 A7 CU20110071 A7 CU 20110071A7
Authority
CU
Cuba
Prior art keywords
compounds
kinase
compositions
inhibitors
kinase proteins
Prior art date
Application number
CU20110071A
Other languages
Spanish (es)
Inventor
Tetsuo Uno
Wenshuo Lu
Wei Pei
Tao Jiang
Yunho Jin
Bei Chen
Iii Thomas H Marsilje
Pierre-Yves Michellys
Original Assignee
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irm Llc filed Critical Irm Llc
Priority to CU20110071A priority Critical patent/CU20110071A7/en
Publication of CU20110071A7 publication Critical patent/CU20110071A7/en

Links

Abstract

La invención proporciona novedosos derivados de pirimidina y piridina y composiciones farmacéuticas de los mismos, y procedimientos para usar tales compuestos. Por ejemplo, los derivados de pirimidina y piridina de la invención pueden usarse para tratar, mejorar o prevenir una afección que responde a la inhibición de actividad de la cinasa del linfoma anaplásico (ALK), cinasa de adhesión focal (FAK), cinasa 70 asociada a la cadena zeta (ZAP-70), factor de crecimiento similar a la insulina (IGF-1R), o una combinación de los mismos.The invention provides novel pyrimidine and pyridine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine and pyridine derivatives of the invention can be used to treat, ameliorate or prevent a condition that responds to the inhibition of anaplastic lymphoma kinase (ALK) activity, focal adhesion kinase (FAK), associated kinase 70 to the zeta chain (ZAP-70), insulin-like growth factor (IGF-1R), or a combination thereof.

CU20110071A 2011-03-31 2011-03-31 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS CU20110071A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20110071A CU20110071A7 (en) 2011-03-31 2011-03-31 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20110071A CU20110071A7 (en) 2011-03-31 2011-03-31 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS

Publications (1)

Publication Number Publication Date
CU20110071A7 true CU20110071A7 (en) 2011-12-28

Family

ID=45508753

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20110071A CU20110071A7 (en) 2011-03-31 2011-03-31 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS

Country Status (1)

Country Link
CU (1) CU20110071A7 (en)

Similar Documents

Publication Publication Date Title
CU20090102A7 (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS
SV2009003290A (en) COMPOUNDS AND COMPOSITIONS AS PROTEIN CINASE INHIBITORS
HN2010002733A (en) COMPOUNDS AND COMPOSITIONS AS CINASE INHIBITORS
MD4650B1 (en) Quinazoline derivatives used to treat HIV
MX339937B (en) Compounds and compositions as c-kit kinase inhibitors.
MX342329B (en) COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS.
CO2018002598A2 (en) Compounds to modulate the expression of angiotensinogen, compositions containing them and processes for their production
GT201300174A (en) INDOL COMPOUNDS OR ANALOGS OF THE SAME USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (DME)
MX2017008520A (en) Fused pyrimidine compounds for the treatment of hiv.
MX2014002486A (en) Compounds and compositions as pdgfr kinase inhibitors.
GT201400261A (en) APPLICATION PCT FACE NATIONAL NOVEDOSAS N-PIRIDINIL AMIDAS CYCLES REPLACED AS QUINASE INHIBITORS
MX2016015565A (en) Certain protein kinase inhibitors.
UY34888A (en) HEPATITIS C VIRUS INHIBITORS
EA201792689A1 (en) DERIVATIVES 2- (PYRAZOLOPIRIDIN-3-IL) Pyrimidine as inhibitors of JAK
EA201692313A1 (en) Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase
MX356813B (en) Hydantoin derivatives useful as kv3 inhibitors.
EA201890364A1 (en) COMPOUNDS SUITABLE FOR INHIBITING ROR-GAMMA-t
PH12014501979A1 (en) Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
CU20110071A7 (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS
CU20100259A7 (en) PIRIMIDINE DERIVATIVES AS QUINASA INHIBITORS